Patisiran vs placebo
Has died · people with TTR‐FAP
Patisiran showed no clear difference in number of participants who died during the trial compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological treatment for familial amyloid polyneuropathy 2020 · Cochrane Headline outcomes onlyRR 0.61 [0.21, 1.74]1 study · 225 participantsLow